Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Rheumatoid arthritis (RA) is an autoimmune chronic disorder that eventually leads to the destruction of bones causing deformities. Signs and symptoms of rheumatoid arthritis include tender, warm, swollen joints, fatigue and fever, and weight loss. Treatment includes non-steroidal anti-inflammatory drugs, corticosteroid medications, and immunosuppressants.

The Rheumatoid Arthritis Drugs in Development market research report provides an overview of the Rheumatoid Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects.

Rheumatoid Arthritis Pipeline Drugs Market Targets

The targets of the Rheumatoid Arthritis pipeline drugs market are Tumor Necrosis Factor, Tyrosine Protein Kinase JAK1, Tyrosine Protein Kinase BTK, Interleukin 6 Receptor, Cells Expressing B Lymphocyte Antigen CD20, Tyrosine Protein Kinase JAK3, Lymphotoxin Alpha, Interleukin 1 Receptor Associated Kinase 4, Interleukin 6, and Non Receptor Tyrosine Protein Kinase TYK2.

Rheumatoid Arthritis pipeline drugs market, by targets

Rheumatoid Arthritis pipeline drugs market, by targets

For more target insights, download a free report sample

Mechanisms of Action of Rheumatoid Arthritis Pipeline Drugs Market

The mechanisms of action of the Rheumatoid Arthritis pipeline drugs market are Tumor Necrosis Factor Inhibitor, Tyrosine Protein Kinase JAK1 Inhibitor, Tyrosine Protein Kinase BTK Inhibitor, Interleukin 6 Receptor Antagonist, Cytotoxic To Cells Expressing B Lymphocyte Antigen CD20, Tyrosine Protein Kinase JAK3 Inhibitor, Lymphotoxin Alpha Inhibitor, Interleukin 1 Receptor Associated Kinase 4 Inhibitor, Interleukin 6 Inhibitor, and Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor.

Rheumatoid Arthritis pipeline drugs market, by mechanisms of action

Rheumatoid Arthritis pipeline drugs market, by mechanisms of action

For more mechanisms of action insights, download a free report sample

Routes of Administration in Rheumatoid Arthritis Pipeline Drugs Market

The routes of administration in the Rheumatoid Arthritis pipeline drugs market are oral, subcutaneous, intravenous, parenteral, topical, intraarticular, Intravenous Drip, transdermal, inhalational, and intramuscular.

Rheumatoid Arthritis pipeline drugs market, by routes of administration

Rheumatoid Arthritis pipeline drugs market, by routes of administration

For more routes of administration insights, download a free report sample

Molecule Types in Rheumatoid Arthritis Pipeline Drugs Market

The molecule types in the Rheumatoid Arthritis pipeline drugs market are small molecule, monoclonal antibody, fusion protein, synthetic peptide, cell therapy, biologic, recombinant protein, peptide, subunit vaccine, and gene therapy.

Rheumatoid Arthritis pipeline drugs market, by molecule types

Rheumatoid Arthritis pipeline drugs market, by molecule types

For more molecule type insights, download a free report sample

Key Rheumatoid Arthritis Pipeline Drugs Market Companies

Some of the key companies in the Rheumatoid Arthritis pipeline drugs market are Amgen Inc, Galapagos NV, Johnson & Johnson, Pfizer Inc, Servatus Ltd, AbbVie Inc, Impetis Biosciences Ltd, SinoMab Bioscience Ltd, Zhejiang Hisun Pharmaceutical Co Ltd, and 3SBio Inc.

Rheumatoid Arthritis pipeline drugs market, by key companies

Rheumatoid Arthritis pipeline drugs market, by key companies

To know more about key companies, download a free report sample

Market report overview

Targets Tumor Necrosis Factor, Tyrosine Protein Kinase JAK1, Tyrosine Protein Kinase BTK, Interleukin 6 Receptor, Cells Expressing B Lymphocyte Antigen CD20, Tyrosine Protein Kinase JAK3, Lymphotoxin Alpha, Interleukin 1 Receptor Associated Kinase 4, Interleukin 6, and Non Receptor Tyrosine Protein Kinase TYK2
Mechanisms of Action Tumor Necrosis Factor Inhibitor, Tyrosine Protein Kinase JAK1 Inhibitor, Tyrosine Protein Kinase BTK Inhibitor, Interleukin 6 Receptor Antagonist, Cytotoxic to Cells Expressing B Lymphocyte Antigen CD20, Tyrosine Protein Kinase JAK3 Inhibitor, Lymphotoxin Alpha Inhibitor, Interleukin 1 Receptor Associated Kinase 4 Inhibitor, Interleukin 6 Inhibitor, and Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor
Routes of Administration Oral, Subcutaneous, Intravenous, Parenteral, Topical, Intraarticular, Intravenous Drip, Transdermal, Inhalational, and Intramuscular
Molecule Types Small Molecule, Monoclonal Antibody, Fusion Protein, Synthetic Peptide, Cell Therapy, Biologic, Recombinant Protein, Peptide, Subunit Vaccine, and Gene Therapy
Key Companies Amgen Inc, Galapagos NV, Johnson & Johnson, Pfizer Inc, Servatus Ltd, AbbVie Inc, Impetis Biosciences Ltd, SinoMab Bioscience Ltd, Zhejiang Hisun Pharmaceutical Co Ltd, and 3SBio Inc

Scope 

This report provides:

  • A snapshot of the global therapeutic landscape of Rheumatoid Arthritis (Immunology).
  • Reviews of pipeline therapeutics for Rheumatoid Arthritis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
  • Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
  • Reviews of key companies involved in Rheumatoid Arthritis (Immunology) therapeutics and enlists all their major and minor projects.
  • Evaluation of Rheumatoid Arthritis (Immunology) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
  • All the dormant and discontinued pipeline projects.
  • Reviews of the latest news and deals related to pipeline therapeutics for Rheumatoid Arthritis (Immunology).

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Rheumatoid Arthritis (Immunology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Rheumatoid Arthritis (Immunology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

180 Life Corp
3SBio Inc
4D Pharma Plc
AB Science SA
AbbVie Inc
Abcentra LLC
Abclon Inc
Abivax SA
Ablynx NV
Abwiz Bio Inc
Accro BioScience (Suzhou) Co Ltd
Aclaris Therapeutics Inc
Adare Pharma Solutions
Affilogic SAS
Ahead Therapeutics SL
AIBIOS Co Ltd
AimVion AS
Akari Therapeutics Plc
Alibion AG
Allied-Bristol Life Sciences LLC
Alphamab Oncology
Alpine Immune Sciences Inc
Aluda Pharmaceuticals Inc
Alvotech ehf
Amgen Inc
Amrif BV
Amtixbio Co Ltd
Amytrx Therapeutics Inc
Annji Pharmaceutical Co Ltd
AnTolRx Inc
Apaxen
Apcegen Technologies Pvt Ltd
Applied Molecular Transport Inc
Aprilbio Co Ltd
Aprogen Inc
Aqilion AB
arGentis Pharmaceuticals LLC
Argenx SE
Arrien Pharmaceuticals LLC
Astellas Pharma Inc
AstraZeneca Plc
Atlanthera
Auransa Inc
Avesthagen Ltd
Avotres Inc
Axsome Therapeutics Inc
Axxam SpA
Bayer AG
Baylx Inc
Beijing Eastern Biotech Co Ltd
Beijing Hanmi Pharmaceutical Co Ltd
Beijing Sanyuan Gene Pharmaceutical Co Ltd
Beijing Toll Biotech Co Ltd
Beijing VDJBio Co Ltd
Bilix Co Ltd
Bio-Cancer Treatment International Ltd
Bio-Thera Solutions Ltd
Biocad
Biocon Ltd
Biogen Inc
Bioiberica SAU
Biois Corp
BioLingus AG
BioXpress Therapeutics SA
Biozeus Pharmaceutical SA
Brickell Biotech Inc
Bristol-Myers Squibb Co
BTB Pharma AB
C4X Discovery Holdings Plc
Can-Fite BioPharma Ltd
Captor Therapeutics SA
Carna Biosciences Inc
CEL-SCI Corp
Cellics Therapeutics Inc
Cellinbio Co Ltd
CELLnLIFE Inc
CellTex Therapeutics Corp
Celltrion Inc
Cellworks Group Inc
Celon Pharma SA
Centivax Inc
Centrymed Pharmaceutical Inc
CheckPoint Immunology Inc
Chengdu Hyperway Pharmaceuticals
Chengdu Jinrui Foundation Biotechnology Co Ltd
China Resources Pharmaceutical Group Ltd
Chong Kun Dang Pharmaceutical Corp
Citryll BV
Clevexel Pharma SA
Clover Biopharmaceuticals
Compugen Ltd
Cour Pharmaceuticals Development Co Inc
Creative Medical Technology Holdings Inc
Crossject SA
CrystalGenomics Inc
CSL Ltd
CSPC Pharmaceutical Group Ltd
cStem Regeneration Pharmaceutical Co Ltd
Cue Biopharma Inc
Cugene Inc
CV6 Therapeutics (Ni) Ltd
Cyclacel Pharmaceuticals Inc
Cyxone AB
Daewoong Pharmaceutical Co Ltd
Deka Biosciences Inc
DeMay Biotech
Denali Therapeutics Inc
Dendright Pty Ltd
Diamyd Medical AB
DiNonA Inc
DNX Biopharmaceuticals Inc
Domainex Ltd
Dr. Reddy's Laboratories Ltd
Ducentis BioTherapeutics Ltd
Dyadic International Inc
Dynavax Technologies Corp
Dyve Biosciences Inc
Egret Therapeutics Inc
EHL Bio Co Ltd
Eli Lilly and Co
Endpoint Health Inc
Enosi Life Sciences Corp
Ensign Pharmaceutical Inc
Enzene Biosciences Ltd
Enzychem Lifesciences Corp
EQRx Inc
Ergon Pharmaceuticals LLC
Eternity Bioscience Inc
Eton Pharmaceuticals Inc
Evotec SE
Exopharm Ltd
Eydis Bio Inc
f5 Therapeutics Inc
Forest Hills Partners Hong Kong Ltd
Foshan Rexie Biotechnology Co Ltd
Fresenius Kabi SwissBioSim GmbH
Future Medicine Co Ltd
Galapagos NV
GB Sciences Inc
Gbiologics Inc
GeneOne Life Science Inc
Generium
Generos Biomedical Technology (Hangzhou) Co Ltd
Genesen Co Ltd
Genor BioPharma Co Ltd
Genova Biotech Company Ltd
Genrix (Shanghai) Biopharmaceutical Co Ltd
Gilead Sciences Inc
Gismo Therapeutics Inc
GlaxoSmithKline Plc
GNT Pharma Co Ltd
Guangdong Yinzhu Pharmaceutical Technology Co Ltd
Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangzhou BeBetter Medicine Technology Co Ltd
Guangzhou Jiayue Pharmaceutical Technology Co Ltd
H. Lundbeck AS
Han Wha Pharma Co Ltd
Hangzhou East China Pharmaceutical Group Co Ltd
Hanlim Pharm Co Ltd
Hebei Fitness Biotechnology Co Ltd
HEC Pharma Co Ltd
HK inno.N Corp
Hope Biosciences LLC
Horizon Therapeutics Plc
Hualan Biological Engineering Inc
HuniLife Biotechnology Inc
Hutchison MediPharma Ltd
I-Mab
iBio Inc
Ichnos Sciences Inc
ICM Co Ltd
Idogen AB
IL-2Rx Inc
Iltoo Pharma
IMBiologics Corp
IMD-Pharma SAS
Immungenetics AG
Immunwork Inc
Immupharma Plc
Immutep Ltd
Impetis Biosciences Ltd
InflammatoRx inc
Inmagene Biopharmaceuticals Ltd
Innovent Biologics Inc
Innovimmune Biotherapeutics Inc
Interprotein Corp
Intrinsic Medicine Inc
Io Therapeutics Inc
Istesso Ltd
Japan Tobacco Inc
Jeil Pharmaceutical Co Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Optixin Biomedical Technology Co Ltd
JiangSu Qyuns Therapeutics Co Ltd
Johnson & Johnson
Jubilant Therapeutics Inc
Jyant Technologies Inc
Kadmon Holdings Inc
Kangstem Biotech Co Ltd
KBP Biosciences Co Ltd
Kemmx Corp
Kezar Life Sciences Inc
Kidswell Bio Corp
KIMS Pharmaceutical Co Ltd
Kine Sciences
Kiniksa Pharmaceuticals Ltd
Korea United Pharm Inc
Kymera Therapeutics, Inc
L2 Diagnostics LLC
Landos Biopharma Inc
Lead Pharma Holding BV
Leukosight Inc
LG Chem Ltd
LipUm AB
LISCure Biosciences Co Ltd
Livzon Pharmaceutical Group Co Ltd
Longwood Biopharmaceuticals Co Ltd
Luckwel Pharmaceuticals Inc
Lupin Ltd
Lynk Pharmaceutical Hangzhou Co Ltd
Mabion SA
Mabpharm Ltd
Mabtech Ltd
Mabwell Shanghai Bioscience Co Ltd
Mabxience Holding SL
Maruho Co Ltd
medac GmbH
MedAnnex Ltd
MeiraGTx Holdings Plc
MENTRIK Biotech LLC
Merck & Co Inc
Mesoblast Ltd
MetiMedi Pharmaceuticals Co Ltd
MetrioPharm AG
Microbiotix Inc
Minghui Pharmaceutical (Shanghai) Co Ltd
Mirae Cell Bio Co Ltd
Mycenax Biotech Inc
MyeloRx LLC
MyMD Pharmaceuticals, Inc
Nano Intelligent Biomedical Engineering Corp
Nanode Therapeutics Inc
Nanolek LLC
Navigen Inc
NeuClone Pty Ltd
Neuracle Science Co Ltd
Nichi-Iko Pharmaceutical Co Ltd
North China Pharmaceutical Group New Drug Research and Development Co Ltd
NovaCell Technology Inc
NovalGen Ltd
Novartis AG
NuBioPharma LLC
Numab Therapeutics AG
Nurix Therapeutics Inc
Octagon Therapeutics Inc
Omeros Corp
Oncodesign SA
Oneness Biotech Co Ltd
Oryn Therapeutics
OSE Immunotherapeutics
Outlook Therapeutics Inc
Pahan Therapeutics
Paras Biopharmaceuticals Finland Oy
Parvus Therapeutics Inc
Peptinov SAS
Pfizer Inc
Pharmaceutical and Cosmetic Solutions Ltd
Pharmapraxis
PKU V-Ming (Hefei) Biologics Co Ltd
Promethera Biosciences SA
ProNoxis AB
Protab Ltd
Qilu Pharmaceutical Co Ltd
Qu Biologics Inc
R-Pharm
Radikal Therapeutics Inc
ReceptoPharm Inc
Regen BioPharma Inc
Regenerative Arthritis & Bone Medicine Inc
Reliance Life Sciences Pvt Ltd
Resolomics Ltd
Resverlogix Corp
Revolo Biotherapeutics Ltd
Rheos Medicines Inc
RheumaGen LLC
Ribomic Inc
Richter Gedeon Nyrt
Rigel Pharmaceuticals Inc
Rise Therapeutics LLC
Rophibio Inc
ROS Therapeutics ApS
Rottapharm Biotech Srl
Saje Pharma LLC
Santhera Pharmaceuticals Holding AG
Sareum Holdings Plc
SBI Biotech Co Ltd
SciRhom GmbH
Sengenics Corp Pte Ltd
Serene LLC
Servatus Ltd
SFA Therapeutics LLC
Shandong Danhong Pharmaceutical Co Ltd
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Shanghai Haiyan Pharmaceutical Technology Co Ltd
Shanghai Junshi Bioscience Co Ltd
Shanghai Novamab Biopharmaceuticals Co Ltd
Shanghai Pharmaceutical Group Co Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Siam Bioscience Co Ltd
Sichuan Kelun Bio-Tech Pharmaceutical Co Ltd
Signablok Inc
Simcere Pharmaceutical Group Ltd
Singh Biotechnology LLC
SinoCelltech Group Ltd
SinoMab Bioscience Ltd
Sinsin Pharmaceutical Co Ltd
siRNAgen Therapeutics Corp
SK Chemicals Co Ltd
Sonoma Biotherapeutics Inc
Sorrento Therapeutics Inc
Splash Pharmaceuticals Inc
Statera Biopharma Inc
Suzhou Connect Biopharmaceuticals Ltd
Suzhou Everhealth Biomedical Co Ltd
Suzhou Sinovent Pharmaceuticals Co Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
SynAct Pharma AB
Synermore Biologics Co Ltd
Taiho Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
Tasly Pharmaceutical Group Co Ltd
Teijin Pharma Ltd
TG Therapeutics Inc
The United Laboratories International Holdings Ltd
Tianjin Hemay Pharmaceutical Co Ltd
Tiziana Life Sciences Plc
TLL Pharmaceutical LLC
Tonix Pharmaceuticals Holding Corp
TPCera Ltd
trajectumPharma BV
Translational Biosciences
Triastek Inc
Tumorend LLC
Turgut Ilaclari AS
United Biomedical Inc
United BioPharma Inc
Vaccinex Inc
Vanworld Pharmaceutical (Rugao) Company Ltd
Vascular Biogenics Ltd
Vir Biotechnology Inc
Worg Pharmaceuticals Hangzhou Co Ltd
Wuhan Institute of Biological Products Co Ltd
Wuhan LL Science and Technology Development Co Ltd
Wuxi Fuxin Pharmaceutical Research and Development Co Ltd
Wyvern Pharmaceuticals Inc
Xalud Therapeutics Inc
XBiotech Inc
XL-protein GmbH
Y-Biologics Inc
Yantai Rongchang Pharmaceutical Co Ltd
Yichang Humanwell Pharmaceutical Co Ltd
Yuhan Corp
Zenas BioPharma (USA) LLC
Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co Ltd
Zhuhai United Laboratories Co Ltd
Zydus Lifesciences Ltd
ZyVersa Therapeutics Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Rheumatoid Arthritis – Overview

Rheumatoid Arthritis – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Rheumatoid Arthritis – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Rheumatoid Arthritis – Companies Involved in Therapeutics Development

Rheumatoid Arthritis – Drug Profiles

Rheumatoid Arthritis – Dormant Projects

Rheumatoid Arthritis – Discontinued Products

Rheumatoid Arthritis – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Table

List of Tables

Number of Products under Development for Rheumatoid Arthritis, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Companies, 2022 (Contd..1)

Number of Products under Development by Companies, 2022 (Contd..2)

Number of Products under Development by Companies, 2022 (Contd..3)

Number of Products under Development by Companies, 2022 (Contd..4)

Number of Products under Development by Companies, 2022 (Contd..5)

Number of Products under Development by Companies, 2022 (Contd..6)

Number of Products under Development by Companies, 2022 (Contd..7)

Number of Products under Development by Companies, 2022 (Contd..8)

Number of Products under Development by Companies, 2022 (Contd..9)

Number of Products under Development by Companies, 2022 (Contd..10)

Number of Products under Development by Companies, 2022 (Contd..11)

Number of Products under Development by Companies, 2022 (Contd..12)

Number of Products under Development by Companies, 2022 (Contd..13)

Number of Products under Development by Companies, 2022 (Contd..14)

Number of Products under Development by Companies, 2022 (Contd..15)

Number of Products under Development by Companies, 2022 (Contd..16)

Number of Products under Development by Companies, 2022 (Contd..17)

Number of Products under Development by Companies, 2022 (Contd..18)

Number of Products under Development by Universities/Institutes, 2022

Number of Products under Development by Universities/Institutes, 2022 (Contd..1)

Products under Development by Companies, 2022

Products under Development by Companies, 2022 (Contd..1)

Products under Development by Companies, 2022 (Contd..2)

Products under Development by Companies, 2022 (Contd..3)

Products under Development by Companies, 2022 (Contd..4)

Products under Development by Companies, 2022 (Contd..5)

Products under Development by Companies, 2022 (Contd..6)

Products under Development by Companies, 2022 (Contd..7)

Products under Development by Companies, 2022 (Contd..8)

Products under Development by Companies, 2022 (Contd..9)

Products under Development by Companies, 2022 (Contd..10)

Products under Development by Companies, 2022 (Contd..11)

Products under Development by Companies, 2022 (Contd..12)

Products under Development by Companies, 2022 (Contd..13)

Products under Development by Companies, 2022 (Contd..14)

Products under Development by Companies, 2022 (Contd..15)

Products under Development by Companies, 2022 (Contd..16)

Products under Development by Companies, 2022 (Contd..17)

Products under Development by Companies, 2022 (Contd..18)

Products under Development by Companies, 2022 (Contd..19)

Products under Development by Companies, 2022 (Contd..20)

Products under Development by Companies, 2022 (Contd..21)

Products under Development by Companies, 2022 (Contd..22)

Products under Development by Companies, 2022 (Contd..23)

Products under Development by Companies, 2022 (Contd..24)

Products under Development by Companies, 2022 (Contd..25)

Products under Development by Universities/Institutes, 2022

Products under Development by Universities/Institutes, 2022 (Contd..1)

Number of Products by Stage and Target, 2022

Number of Products by Stage and Target, 2022 (Contd..1)

Number of Products by Stage and Target, 2022 (Contd..2)

Number of Products by Stage and Target, 2022 (Contd..3)

Number of Products by Stage and Target, 2022 (Contd..4)

Number of Products by Stage and Target, 2022 (Contd..5)

Number of Products by Stage and Target, 2022 (Contd..6)

Number of Products by Stage and Target, 2022 (Contd..7)

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..3)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..4)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..5)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..6)

Number of Products by Stage and Mechanism of Action, 2022 (Contd..7)

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Rheumatoid Arthritis – Pipeline by 180 Life Corp, 2022

Rheumatoid Arthritis – Pipeline by 3SBio Inc, 2022

Rheumatoid Arthritis – Pipeline by 4D Pharma Plc, 2022

Rheumatoid Arthritis – Pipeline by AB Science SA, 2022

Rheumatoid Arthritis – Pipeline by AbbVie Inc, 2022

Rheumatoid Arthritis – Pipeline by Abcentra LLC, 2022

Rheumatoid Arthritis – Pipeline by Abclon Inc, 2022

Rheumatoid Arthritis – Pipeline by Abivax SA, 2022

Rheumatoid Arthritis – Pipeline by Ablynx NV, 2022

Rheumatoid Arthritis – Pipeline by Abwiz Bio Inc, 2022

Rheumatoid Arthritis – Pipeline by Accro BioScience (Suzhou) Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Aclaris Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Adare Pharma Solutions, 2022

Rheumatoid Arthritis – Pipeline by Affilogic SAS, 2022

Rheumatoid Arthritis – Pipeline by Ahead Therapeutics SL, 2022

Rheumatoid Arthritis – Pipeline by AIBIOS Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by AimVion AS, 2022

Rheumatoid Arthritis – Pipeline by Akari Therapeutics Plc, 2022

Rheumatoid Arthritis – Pipeline by Alibion AG, 2022

Rheumatoid Arthritis – Pipeline by Allied-Bristol Life Sciences LLC, 2022

Rheumatoid Arthritis – Pipeline by Alphamab Oncology, 2022

Rheumatoid Arthritis – Pipeline by Alpine Immune Sciences Inc, 2022

Rheumatoid Arthritis – Pipeline by Aluda Pharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Alvotech ehf, 2022

Rheumatoid Arthritis – Pipeline by Amgen Inc, 2022

Rheumatoid Arthritis – Pipeline by Amrif BV, 2022

Rheumatoid Arthritis – Pipeline by Amtixbio Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Amytrx Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Annji Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by AnTolRx Inc, 2022

Rheumatoid Arthritis – Pipeline by Apaxen, 2022

Rheumatoid Arthritis – Pipeline by Apcegen Technologies Pvt Ltd, 2022

Rheumatoid Arthritis – Pipeline by Applied Molecular Transport Inc, 2022

Rheumatoid Arthritis – Pipeline by Aprilbio Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Aprogen Inc, 2022

Rheumatoid Arthritis – Pipeline by Aqilion AB, 2022

Rheumatoid Arthritis – Pipeline by arGentis Pharmaceuticals LLC, 2022

Rheumatoid Arthritis – Pipeline by Argenx SE, 2022

Rheumatoid Arthritis – Pipeline by Arrien Pharmaceuticals LLC, 2022

Rheumatoid Arthritis – Pipeline by Astellas Pharma Inc, 2022

Rheumatoid Arthritis – Pipeline by AstraZeneca Plc, 2022

Rheumatoid Arthritis – Pipeline by Atlanthera, 2022

Rheumatoid Arthritis – Pipeline by Auransa Inc, 2022

Rheumatoid Arthritis – Pipeline by Avesthagen Ltd, 2022

Rheumatoid Arthritis – Pipeline by Avotres Inc, 2022

Rheumatoid Arthritis – Pipeline by Axsome Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Axxam SpA, 2022

Rheumatoid Arthritis – Pipeline by Bayer AG, 2022

Rheumatoid Arthritis – Pipeline by Baylx Inc, 2022

Rheumatoid Arthritis – Pipeline by Beijing Eastern Biotech Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Beijing Sanyuan Gene Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Beijing Toll Biotech Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Beijing VDJBio Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Bilix Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Bio-Cancer Treatment International Ltd, 2022

Rheumatoid Arthritis – Pipeline by Bio-Thera Solutions Ltd, 2022

Rheumatoid Arthritis – Pipeline by Biocad, 2022

Rheumatoid Arthritis – Pipeline by Biocon Ltd, 2022

Rheumatoid Arthritis – Pipeline by Biogen Inc, 2022

Rheumatoid Arthritis – Pipeline by Bioiberica SAU, 2022

Rheumatoid Arthritis – Pipeline by Biois Corp, 2022

Rheumatoid Arthritis – Pipeline by BioLingus AG, 2022

Rheumatoid Arthritis – Pipeline by BioXpress Therapeutics SA, 2022

Rheumatoid Arthritis – Pipeline by Biozeus Pharmaceutical SA, 2022

Rheumatoid Arthritis – Pipeline by Brickell Biotech Inc, 2022

Rheumatoid Arthritis – Pipeline by Bristol-Myers Squibb Co, 2022

Rheumatoid Arthritis – Pipeline by BTB Pharma AB, 2022

Rheumatoid Arthritis – Pipeline by C4X Discovery Holdings Plc, 2022

Rheumatoid Arthritis – Pipeline by Can-Fite BioPharma Ltd, 2022

Rheumatoid Arthritis – Pipeline by Captor Therapeutics SA, 2022

Rheumatoid Arthritis – Pipeline by Carna Biosciences Inc, 2022

Rheumatoid Arthritis – Pipeline by CEL-SCI Corp, 2022

Rheumatoid Arthritis – Pipeline by Cellics Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Cellinbio Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by CELLnLIFE Inc, 2022

Rheumatoid Arthritis – Pipeline by CellTex Therapeutics Corp, 2022

Rheumatoid Arthritis – Pipeline by Celltrion Inc, 2022

Rheumatoid Arthritis – Pipeline by Cellworks Group Inc, 2022

Rheumatoid Arthritis – Pipeline by Celon Pharma SA, 2022

Rheumatoid Arthritis – Pipeline by Centivax Inc, 2022

Rheumatoid Arthritis – Pipeline by Centrymed Pharmaceutical Inc, 2022

Rheumatoid Arthritis – Pipeline by CheckPoint Immunology Inc, 2022

Rheumatoid Arthritis – Pipeline by Chengdu Hyperway Pharmaceuticals, 2022

Rheumatoid Arthritis – Pipeline by Chengdu Jinrui Foundation Biotechnology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by China Resources Pharmaceutical Group Ltd, 2022

Rheumatoid Arthritis – Pipeline by Chong Kun Dang Pharmaceutical Corp, 2022

Rheumatoid Arthritis – Pipeline by Citryll BV, 2022

Rheumatoid Arthritis – Pipeline by Clevexel Pharma SA, 2022

Rheumatoid Arthritis – Pipeline by Clover Biopharmaceuticals, 2022

Rheumatoid Arthritis – Pipeline by Compugen Ltd, 2022

Rheumatoid Arthritis – Pipeline by Cour Pharmaceuticals Development Co Inc, 2022

Rheumatoid Arthritis – Pipeline by Creative Medical Technology Holdings Inc, 2022

Rheumatoid Arthritis – Pipeline by Crossject SA, 2022

Rheumatoid Arthritis – Pipeline by CrystalGenomics Inc, 2022

Rheumatoid Arthritis – Pipeline by CSL Ltd, 2022

Rheumatoid Arthritis – Pipeline by CSPC Pharmaceutical Group Ltd, 2022

Rheumatoid Arthritis – Pipeline by cStem Regeneration Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Cue Biopharma Inc, 2022

Rheumatoid Arthritis – Pipeline by Cugene Inc, 2022

Rheumatoid Arthritis – Pipeline by CV6 Therapeutics (Ni) Ltd, 2022

Rheumatoid Arthritis – Pipeline by Cyclacel Pharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Cyxone AB, 2022

Rheumatoid Arthritis – Pipeline by Daewoong Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Deka Biosciences Inc, 2022

Rheumatoid Arthritis – Pipeline by DeMay Biotech, 2022

Rheumatoid Arthritis – Pipeline by Denali Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Dendright Pty Ltd, 2022

Rheumatoid Arthritis – Pipeline by Diamyd Medical AB, 2022

Rheumatoid Arthritis – Pipeline by DiNonA Inc, 2022

Rheumatoid Arthritis – Pipeline by DNX Biopharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Domainex Ltd, 2022

Rheumatoid Arthritis – Pipeline by Dr. Reddy’s Laboratories Ltd, 2022

Rheumatoid Arthritis – Pipeline by Ducentis BioTherapeutics Ltd, 2022

Rheumatoid Arthritis – Pipeline by Dyadic International Inc, 2022

Rheumatoid Arthritis – Pipeline by Dynavax Technologies Corp, 2022

Rheumatoid Arthritis – Pipeline by Dyve Biosciences Inc, 2022

Rheumatoid Arthritis – Pipeline by Egret Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by EHL Bio Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Eli Lilly and Co, 2022

Rheumatoid Arthritis – Pipeline by Endpoint Health Inc, 2022

Rheumatoid Arthritis – Pipeline by Enosi Life Sciences Corp, 2022

Rheumatoid Arthritis – Pipeline by Ensign Pharmaceutical Inc, 2022

Rheumatoid Arthritis – Pipeline by Enzene Biosciences Ltd, 2022

Rheumatoid Arthritis – Pipeline by Enzychem Lifesciences Corp, 2022

Rheumatoid Arthritis – Pipeline by EQRx Inc, 2022

Rheumatoid Arthritis – Pipeline by Ergon Pharmaceuticals LLC, 2022

Rheumatoid Arthritis – Pipeline by Eternity Bioscience Inc, 2022

Rheumatoid Arthritis – Pipeline by Eton Pharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Evotec SE, 2022

Rheumatoid Arthritis – Pipeline by Exopharm Ltd, 2022

Rheumatoid Arthritis – Pipeline by Eydis Bio Inc, 2022

Rheumatoid Arthritis – Pipeline by f5 Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Forest Hills Partners Hong Kong Ltd, 2022

Rheumatoid Arthritis – Pipeline by Foshan Rexie Biotechnology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Fresenius Kabi SwissBioSim GmbH, 2022

Rheumatoid Arthritis – Pipeline by Future Medicine Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Galapagos NV, 2022

Rheumatoid Arthritis – Pipeline by GB Sciences Inc, 2022

Rheumatoid Arthritis – Pipeline by Gbiologics Inc, 2022

Rheumatoid Arthritis – Pipeline by GeneOne Life Science Inc, 2022

Rheumatoid Arthritis – Pipeline by Generium, 2022

Rheumatoid Arthritis – Pipeline by Generos Biomedical Technology (Hangzhou) Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Genesen Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Genor BioPharma Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Genova Biotech Company Ltd, 2022

Rheumatoid Arthritis – Pipeline by Genrix (Shanghai) Biopharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Gilead Sciences Inc, 2022

Rheumatoid Arthritis – Pipeline by Gismo Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by GlaxoSmithKline Plc, 2022

Rheumatoid Arthritis – Pipeline by GNT Pharma Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Guangdong Yinzhu Pharmaceutical Technology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Guangzhou BeBetter Medicine Technology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Guangzhou Jiayue Pharmaceutical Technology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by H. Lundbeck AS, 2022

Rheumatoid Arthritis – Pipeline by Han Wha Pharma Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Hangzhou East China Pharmaceutical Group Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Hanlim Pharm Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Hebei Fitness Biotechnology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by HEC Pharma Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by HK inno.N Corp, 2022

Rheumatoid Arthritis – Pipeline by Hope Biosciences LLC, 2022

Rheumatoid Arthritis – Pipeline by Horizon Therapeutics Plc, 2022

Rheumatoid Arthritis – Pipeline by Hualan Biological Engineering Inc, 2022

Rheumatoid Arthritis – Pipeline by HuniLife Biotechnology Inc, 2022

Rheumatoid Arthritis – Pipeline by Hutchison MediPharma Ltd, 2022

Rheumatoid Arthritis – Pipeline by I-Mab, 2022

Rheumatoid Arthritis – Pipeline by iBio Inc, 2022

Rheumatoid Arthritis – Pipeline by Ichnos Sciences Inc, 2022

Rheumatoid Arthritis – Pipeline by ICM Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Idogen AB, 2022

Rheumatoid Arthritis – Pipeline by IL-2Rx Inc, 2022

Rheumatoid Arthritis – Pipeline by Iltoo Pharma, 2022

Rheumatoid Arthritis – Pipeline by IMBiologics Corp, 2022

Rheumatoid Arthritis – Pipeline by IMD-Pharma SAS, 2022

Rheumatoid Arthritis – Pipeline by Immungenetics AG, 2022

Rheumatoid Arthritis – Pipeline by Immunwork Inc, 2022

Rheumatoid Arthritis – Pipeline by Immupharma Plc, 2022

Rheumatoid Arthritis – Pipeline by Immutep Ltd, 2022

Rheumatoid Arthritis – Pipeline by Impetis Biosciences Ltd, 2022

Rheumatoid Arthritis – Pipeline by InflammatoRx inc, 2022

Rheumatoid Arthritis – Pipeline by Inmagene Biopharmaceuticals Ltd, 2022

Rheumatoid Arthritis – Pipeline by Innovent Biologics Inc, 2022

Rheumatoid Arthritis – Pipeline by Innovimmune Biotherapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Interprotein Corp, 2022

Rheumatoid Arthritis – Pipeline by Intrinsic Medicine Inc, 2022

Rheumatoid Arthritis – Pipeline by Io Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Istesso Ltd, 2022

Rheumatoid Arthritis – Pipeline by Japan Tobacco Inc, 2022

Rheumatoid Arthritis – Pipeline by Jeil Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Jiangsu Carephar Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Jiangsu Optixin Biomedical Technology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by JiangSu Qyuns Therapeutics Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Johnson & Johnson, 2022

Rheumatoid Arthritis – Pipeline by Jubilant Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Jyant Technologies Inc, 2022

Rheumatoid Arthritis – Pipeline by Kadmon Holdings Inc, 2022

Rheumatoid Arthritis – Pipeline by Kangstem Biotech Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by KBP Biosciences Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Kemmx Corp, 2022

Rheumatoid Arthritis – Pipeline by Kezar Life Sciences Inc, 2022

Rheumatoid Arthritis – Pipeline by Kidswell Bio Corp, 2022

Rheumatoid Arthritis – Pipeline by KIMS Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Kine Sciences, 2022

Rheumatoid Arthritis – Pipeline by Kiniksa Pharmaceuticals Ltd, 2022

Rheumatoid Arthritis – Pipeline by Korea United Pharm Inc, 2022

Rheumatoid Arthritis – Pipeline by Kymera Therapeutics, Inc, 2022

Rheumatoid Arthritis – Pipeline by L2 Diagnostics LLC, 2022

Rheumatoid Arthritis – Pipeline by Landos Biopharma Inc, 2022

Rheumatoid Arthritis – Pipeline by Lead Pharma Holding BV, 2022

Rheumatoid Arthritis – Pipeline by Leukosight Inc, 2022

Rheumatoid Arthritis – Pipeline by LG Chem Ltd, 2022

Rheumatoid Arthritis – Pipeline by LipUm AB, 2022

Rheumatoid Arthritis – Pipeline by LISCure Biosciences Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Livzon Pharmaceutical Group Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Longwood Biopharmaceuticals Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Luckwel Pharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Lupin Ltd, 2022

Rheumatoid Arthritis – Pipeline by Lynk Pharmaceutical Hangzhou Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Mabion SA, 2022

Rheumatoid Arthritis – Pipeline by Mabpharm Ltd, 2022

Rheumatoid Arthritis – Pipeline by Mabtech Ltd, 2022

Rheumatoid Arthritis – Pipeline by Mabwell Shanghai Bioscience Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Mabxience Holding SL, 2022

Rheumatoid Arthritis – Pipeline by Maruho Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by medac GmbH, 2022

Rheumatoid Arthritis – Pipeline by MedAnnex Ltd, 2022

Rheumatoid Arthritis – Pipeline by MeiraGTx Holdings Plc, 2022

Rheumatoid Arthritis – Pipeline by MENTRIK Biotech LLC, 2022

Rheumatoid Arthritis – Pipeline by Merck & Co Inc, 2022

Rheumatoid Arthritis – Pipeline by Mesoblast Ltd, 2022

Rheumatoid Arthritis – Pipeline by MetiMedi Pharmaceuticals Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by MetrioPharm AG, 2022

Rheumatoid Arthritis – Pipeline by Microbiotix Inc, 2022

Rheumatoid Arthritis – Pipeline by Minghui Pharmaceutical (Shanghai) Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Mirae Cell Bio Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Mycenax Biotech Inc, 2022

Rheumatoid Arthritis – Pipeline by MyeloRx LLC, 2022

Rheumatoid Arthritis – Pipeline by MyMD Pharmaceuticals, Inc, 2022

Rheumatoid Arthritis – Pipeline by Nano Intelligent Biomedical Engineering Corp, 2022

Rheumatoid Arthritis – Pipeline by Nanode Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Nanolek LLC, 2022

Rheumatoid Arthritis – Pipeline by Navigen Inc, 2022

Rheumatoid Arthritis – Pipeline by NeuClone Pty Ltd, 2022

Rheumatoid Arthritis – Pipeline by Neuracle Science Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Nichi-Iko Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by North China Pharmaceutical Group New Drug Research and Development Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by NovaCell Technology Inc, 2022

Rheumatoid Arthritis – Pipeline by NovalGen Ltd, 2022

Rheumatoid Arthritis – Pipeline by Novartis AG, 2022

Rheumatoid Arthritis – Pipeline by NuBioPharma LLC, 2022

Rheumatoid Arthritis – Pipeline by Numab Therapeutics AG, 2022

Rheumatoid Arthritis – Pipeline by Nurix Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Octagon Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Omeros Corp, 2022

Rheumatoid Arthritis – Pipeline by Oncodesign SA, 2022

Rheumatoid Arthritis – Pipeline by Oneness Biotech Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Oryn Therapeutics, 2022

Rheumatoid Arthritis – Pipeline by OSE Immunotherapeutics, 2022

Rheumatoid Arthritis – Pipeline by Outlook Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Pahan Therapeutics, 2022

Rheumatoid Arthritis – Pipeline by Paras Biopharmaceuticals Finland Oy, 2022

Rheumatoid Arthritis – Pipeline by Parvus Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Peptinov SAS, 2022

Rheumatoid Arthritis – Pipeline by Pfizer Inc, 2022

Rheumatoid Arthritis – Pipeline by Pharmaceutical and Cosmetic Solutions Ltd, 2022

Rheumatoid Arthritis – Pipeline by Pharmapraxis, 2022

Rheumatoid Arthritis – Pipeline by PKU V-Ming (Hefei) Biologics Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Promethera Biosciences SA, 2022

Rheumatoid Arthritis – Pipeline by ProNoxis AB, 2022

Rheumatoid Arthritis – Pipeline by Protab Ltd, 2022

Rheumatoid Arthritis – Pipeline by Qilu Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Qu Biologics Inc, 2022

Rheumatoid Arthritis – Pipeline by R-Pharm, 2022

Rheumatoid Arthritis – Pipeline by Radikal Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by ReceptoPharm Inc, 2022

Rheumatoid Arthritis – Pipeline by Regen BioPharma Inc, 2022

Rheumatoid Arthritis – Pipeline by Regenerative Arthritis & Bone Medicine Inc, 2022

Rheumatoid Arthritis – Pipeline by Reliance Life Sciences Pvt Ltd, 2022

Rheumatoid Arthritis – Pipeline by Resolomics Ltd, 2022

Rheumatoid Arthritis – Pipeline by Resverlogix Corp, 2022

Rheumatoid Arthritis – Pipeline by Revolo Biotherapeutics Ltd, 2022

Rheumatoid Arthritis – Pipeline by Rheos Medicines Inc, 2022

Rheumatoid Arthritis – Pipeline by RheumaGen LLC, 2022

Rheumatoid Arthritis – Pipeline by Ribomic Inc, 2022

Rheumatoid Arthritis – Pipeline by Richter Gedeon Nyrt, 2022

Rheumatoid Arthritis – Pipeline by Rigel Pharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Rise Therapeutics LLC, 2022

Rheumatoid Arthritis – Pipeline by Rophibio Inc, 2022

Rheumatoid Arthritis – Pipeline by ROS Therapeutics ApS, 2022

Rheumatoid Arthritis – Pipeline by Rottapharm Biotech Srl, 2022

Rheumatoid Arthritis – Pipeline by Saje Pharma LLC, 2022

Rheumatoid Arthritis – Pipeline by Santhera Pharmaceuticals Holding AG, 2022

Rheumatoid Arthritis – Pipeline by Sareum Holdings Plc, 2022

Rheumatoid Arthritis – Pipeline by SBI Biotech Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by SciRhom GmbH, 2022

Rheumatoid Arthritis – Pipeline by Sengenics Corp Pte Ltd, 2022

Rheumatoid Arthritis – Pipeline by Serene LLC, 2022

Rheumatoid Arthritis – Pipeline by Servatus Ltd, 2022

Rheumatoid Arthritis – Pipeline by SFA Therapeutics LLC, 2022

Rheumatoid Arthritis – Pipeline by Shandong Danhong Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Shanghai Haiyan Pharmaceutical Technology Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Shanghai Junshi Bioscience Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Shanghai Pharmaceutical Group Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Siam Bioscience Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Sichuan Kelun Bio-Tech Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Signablok Inc, 2022

Rheumatoid Arthritis – Pipeline by Simcere Pharmaceutical Group Ltd, 2022

Rheumatoid Arthritis – Pipeline by Singh Biotechnology LLC, 2022

Rheumatoid Arthritis – Pipeline by SinoCelltech Group Ltd, 2022

Rheumatoid Arthritis – Pipeline by SinoMab Bioscience Ltd, 2022

Rheumatoid Arthritis – Pipeline by Sinsin Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by siRNAgen Therapeutics Corp, 2022

Rheumatoid Arthritis – Pipeline by SK Chemicals Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Sonoma Biotherapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Sorrento Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by Splash Pharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Statera Biopharma Inc, 2022

Rheumatoid Arthritis – Pipeline by Suzhou Connect Biopharmaceuticals Ltd, 2022

Rheumatoid Arthritis – Pipeline by Suzhou Everhealth Biomedical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Suzhou Sinovent Pharmaceuticals Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by SynAct Pharma AB, 2022

Rheumatoid Arthritis – Pipeline by Synermore Biologics Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Taiho Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Takeda Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Tasly Pharmaceutical Group Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Teijin Pharma Ltd, 2022

Rheumatoid Arthritis – Pipeline by TG Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by The United Laboratories International Holdings Ltd, 2022

Rheumatoid Arthritis – Pipeline by Tianjin Hemay Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Tiziana Life Sciences Plc, 2022

Rheumatoid Arthritis – Pipeline by TLL Pharmaceutical LLC, 2022

Rheumatoid Arthritis – Pipeline by Tonix Pharmaceuticals Holding Corp, 2022

Rheumatoid Arthritis – Pipeline by TPCera Ltd, 2022

Rheumatoid Arthritis – Pipeline by trajectumPharma BV, 2022

Rheumatoid Arthritis – Pipeline by Translational Biosciences, 2022

Rheumatoid Arthritis – Pipeline by Triastek Inc, 2022

Rheumatoid Arthritis – Pipeline by Tumorend LLC, 2022

Rheumatoid Arthritis – Pipeline by Turgut Ilaclari AS, 2022

Rheumatoid Arthritis – Pipeline by United Biomedical Inc, 2022

Rheumatoid Arthritis – Pipeline by United BioPharma Inc, 2022

Rheumatoid Arthritis – Pipeline by Vaccinex Inc, 2022

Rheumatoid Arthritis – Pipeline by Vanworld Pharmaceutical (Rugao) Company Ltd, 2022

Rheumatoid Arthritis – Pipeline by Vascular Biogenics Ltd, 2022

Rheumatoid Arthritis – Pipeline by Vir Biotechnology Inc, 2022

Rheumatoid Arthritis – Pipeline by Worg Pharmaceuticals Hangzhou Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Wuhan Institute of Biological Products Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Wuhan LL Science and Technology Development Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Wuxi Fuxin Pharmaceutical Research and Development Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Wyvern Pharmaceuticals Inc, 2022

Rheumatoid Arthritis – Pipeline by Xalud Therapeutics Inc, 2022

Rheumatoid Arthritis – Pipeline by XBiotech Inc, 2022

Rheumatoid Arthritis – Pipeline by XL-protein GmbH, 2022

Rheumatoid Arthritis – Pipeline by Y-Biologics Inc, 2022

Rheumatoid Arthritis – Pipeline by Yantai Rongchang Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Yichang Humanwell Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Yuhan Corp, 2022

Rheumatoid Arthritis – Pipeline by Zenas BioPharma (USA) LLC, 2022

Rheumatoid Arthritis – Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Zhejiang Yatai Pharmaceutical Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Zhuhai United Laboratories Co Ltd, 2022

Rheumatoid Arthritis – Pipeline by Zydus Lifesciences Ltd, 2022

Rheumatoid Arthritis – Pipeline by ZyVersa Therapeutics Inc, 2022

Rheumatoid Arthritis – Dormant Projects, 2022

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..1)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..2)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..3)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..4)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..5)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..6)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..7)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..8)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..9)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..10)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..11)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..12)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..13)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..14)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..15)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..16)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..17)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..18)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..19)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..20)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..21)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..22)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..23)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..24)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..25)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..26)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..27)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..28)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..29)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..30)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..31)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..32)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..33)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..34)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..35)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..36)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..37)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..38)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..39)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..40)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..41)

Rheumatoid Arthritis – Dormant Projects, 2022 (Contd..42)

Rheumatoid Arthritis – Discontinued Products, 2022

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..1)

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..2)

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..3)

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..4)

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..5)

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..6)

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..7)

Rheumatoid Arthritis – Discontinued Products, 2022 (Contd..8)

Figures

List of Figures

Number of Products under Development for Rheumatoid Arthritis, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Number of Products by Top 10 Targets, 2022

Number of Products by Stage and Top 10 Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Top 10 Routes of Administration, 2022

Number of Products by Stage and Top 10 Routes of Administration, 2022

Number of Products by Top 10 Molecule Types, 2022

Number of Products by Stage and Top 10 Molecule Types, 2022

Frequently asked questions

Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

  • Access a live Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.